tiprankstipranks
Trending News
More News >
Apyx Medical Corporation (APYX)
NASDAQ:APYX
US Market

Apyx Medical (APYX) Earnings Dates, Call Summary & Reports

Compare
192 Followers

Earnings Data

Report Date
Aug 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.09
Last Year’s EPS
-0.19
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 08, 2025
|
% Change Since: 14.40%
|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment with several positive developments such as growth in advanced energy products, successful cost-cutting, and market recognition for Renuvion, alongside challenges like a significant decline in total and OEM revenues. The company is optimistic about future growth with the upcoming AYON platform launch.
Company Guidance
In the first quarter of 2025, Apyx Medical reported total revenue of $9.4 million, marking an 8% decrease from the $10.2 million in the same period the previous year. The company's Advanced Energy segment saw a 6% increase in sales to $7.9 million, driven by stronger sales of single-use handpieces in the U.S., despite a decline in OEM sales by 44.7%. Operating expenses decreased significantly to $8.7 million from $12.6 million, largely due to cost-cutting measures. Net loss attributable to shareholders was reduced to $4.2 million, or $0.10 per share, compared to $7.6 million, or $0.22 per share, in the prior year. The company maintained a strong cash position, with $31 million in cash and cash equivalents, and reiterated its full-year 2025 revenue guidance of $47.6 million to $49 million. Apyx is preparing for the launch of its AYON body contouring platform in late 2025, pending FDA clearance, which it expects will bolster equipment sales growth.
Advanced Energy Product Sales Growth
Sales of advanced energy products increased by 6% to $7.9 million in the first quarter of 2025 compared to the same period last year, indicating a positive trend in the U.S. market with stronger sales of single-use handpieces.
Cost-Cutting and Restructuring Success
Significant cost-cutting measures and a restructuring program have been implemented, resulting in reduced costs and cash burn, showcasing dedication to commercial strategy.
Renuvion's Market Recognition
Renuvion won the 2025 NewBeauty Award for best minimally invasive skin tightener, highlighting the innovation and effectiveness of the product in the aesthetic space.
AYON Platform Launch Preparedness
Plans for a soft launch of the AYON platform in the back half of 2025 are in place, indicating readiness to expand market share and address a growing aesthetic surgery market.
Improved Financial Metrics
Net loss attributable to shareholders decreased to $4.2 million from $7.6 million in the prior year. Adjusted EBITDA loss also decreased by 54% to $2.4 million.
Positive Cash Flow Management
Cash used in operating activities decreased significantly to $0.7 million from $6.3 million in the prior year, with expectations to return to normalized cash burn for the balance of 2025.
---

Apyx Medical (APYX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

APYX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 07, 2025
2025 (Q2)
-0.09 / -
-0.19
May 08, 2025
2025 (Q1)
-0.12 / -0.10
-0.2254.55% (+0.12)
Mar 13, 2025
2024 (Q4)
-0.16 / -0.12
-0.2857.14% (+0.16)
Nov 08, 2024
2024 (Q3)
-0.18 / -0.14
-0.13-7.69% (-0.01)
Aug 08, 2024
2024 (Q2)
-0.20 / -0.19
-0.03-533.33% (-0.16)
May 09, 2024
2024 (Q1)
-0.22 / -0.22
-0.1-120.00% (-0.12)
Mar 21, 2024
2023 (Q4)
-0.18 / -0.28
-0.17-64.71% (-0.11)
Nov 09, 2023
2023 (Q3)
-0.11 / -0.13
-0.1723.53% (+0.04)
Aug 10, 2023
2023 (Q2)
-0.07 / -0.03
-0.1681.25% (+0.13)
May 11, 2023
2023 (Q1)
-0.14 / -0.10
-0.1741.18% (+0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

APYX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 08, 2025
$1.25$1.18-5.60%
Mar 13, 2025
$1.07$1.04-2.80%
Nov 08, 2024
$1.22$1.52+24.59%
Aug 08, 2024
$1.02$1.04+1.96%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Apyx Medical Corporation (APYX) report earnings?
Apyx Medical Corporation (APYX) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
    What is Apyx Medical Corporation (APYX) earnings time?
    Apyx Medical Corporation (APYX) earnings time is at Aug 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is APYX EPS forecast?
          APYX EPS forecast for the fiscal quarter 2025 (Q2) is -0.09.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis